Regulation of cdk2 activity in endothelial cells that are inhibited from growth by cell contact

被引:39
作者
Chen, DH
Walsh, K
Wang, J
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Div Cardiovasc, Indianapolis, IN 46285 USA
[2] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Div Cardiovasc Res, Boston, MA 02111 USA
关键词
cell cycle; contact inhibition; endothelium;
D O I
10.1161/01.ATV.20.3.629
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelial cells (ECs) are quiescent in normal blood vessels but undergo rapid bursts of proliferation after vascular injury and during angiogenesis. Here we show that the activity of cyclin-dependent kinase-2 (cdk2), a key regulator of the G1 and S phases of the cell cycle, is expressed at high levels in proliferating ECs but at low levels in ECs that are contact-inhibited for growth. Despite these differences in kinase activity, the protein levels of cdk2 and 1 of its activating subunits, cyclin E, are not modulated by these different growth conditions. The cdk inhibitor p27 is highly expressed in contact-inhibited but not proliferating ECs, whereas the level of cyclin A protein is preferentially expressed in proliferating ECs. p27 protein was detected in immunoprecipitable complexes with cdk2 or cyclin E in cultures that were contact-inhibited for growth. The functional significance of the p27 induction was indicated by the detection of a heat-stable cdk2 inhibitory activity that was induced by endothelial cell-cell contact and could be immunodepleted with anti-p27 antibodies. In a confluent EC monolayer, cdk2 kinase activity was activated by a scraping injury that led to cell migration and proliferation. The injury-induced activation of cdk2 coincided with the downregulation of p27 and the induction of cyclin A. These data demonstrate that p27 is induced in confluent cultures of ECs. They also indicate that both p27 induction and cyclin A downregulation contribute to the inhibition of cdk2 and cell proliferation by cell-cell contact in ECs.
引用
收藏
页码:629 / 635
页数:7
相关论文
共 48 条
  • [31] Poluha W, 1996, MOL CELL BIOL, V16, P1335
  • [32] CLONING OF P27(KIP1), A CYCLIN-DEPENDENT KINASE INHIBITOR AND A POTENTIAL MEDIATOR OF EXTRACELLULAR ANTIMITOGENIC SIGNALS
    POLYAK, K
    LEE, MH
    ERDJUMENTBROMAGE, H
    KOFF, A
    ROBERTS, JM
    TEMPST, P
    MASSAGUE, J
    [J]. CELL, 1994, 78 (01) : 59 - 66
  • [33] P27(KIP1), A CYCLIN-CDK INHIBITOR, LINKS TRANSFORMING GROWTH-FACTOR-BETA AND CONTACT INHIBITION TO CELL-CYCLE ARREST
    POLYAK, K
    KATO, JY
    SOLOMON, MJ
    SHERR, CJ
    MASSAGUE, J
    ROBERTS, JM
    KOFF, A
    [J]. GENES & DEVELOPMENT, 1994, 8 (01) : 9 - 22
  • [34] ACCELERATION OF THE G(1)/S PHASE-TRANSITION BY EXPRESSION OF CYCLIN-D1 AND CYCLIN-E WITH AN INDUCIBLE SYSTEM
    RESNITZKY, D
    GOSSEN, M
    BUJARD, H
    REED, SI
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) : 1669 - 1679
  • [35] THE PATHOGENESIS OF ATHEROSCLEROSIS - A PERSPECTIVE FOR THE 1990S
    ROSS, R
    [J]. NATURE, 1993, 362 (6423) : 801 - 809
  • [36] GROWTH-CONTROL AND MORPHOGENESIS IN THE DEVELOPMENT AND PATHOLOGY OF ARTERIES
    SCHWARTZ, SM
    LIAW, L
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 : S31 - S49
  • [37] Cancer cell cycles
    Sherr, CJ
    [J]. SCIENCE, 1996, 274 (5293) : 1672 - 1677
  • [38] Suppression of p53 activity and p21(WAF1/CIP1) expression by vascular cell integrin alpha v beta 3 during angiogenesis
    Stromblad, S
    Becker, JC
    Yebra, M
    Brooks, PC
    Cheresh, DA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) : 426 - 433
  • [39] Expression of cyclin-dependent kinase inhibitors in vascular disease
    Tanner, FC
    Yang, ZY
    Duckers, E
    Gordon, D
    Nabel, GJ
    Nabel, EG
    [J]. CIRCULATION RESEARCH, 1998, 82 (03) : 396 - 403
  • [40] Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation
    Wang, J
    Walsh, K
    [J]. SCIENCE, 1996, 273 (5273) : 359 - 361